Trelleborg Q1 Report 2024

Highlights

• Net sales for the quarter declined 5 percent to SEK 8,234 M (8,711). Organic sales declined 3 percent compared with the preceding year, structural changes reduced sales by 2 percent and currency was unchanged compared with the preceding year.
• EBITA, excluding items affecting comparability, decreased 2 percent to SEK 1,490 M (1,528). The EBITA margin was 18.1 percent (17.5).
• Operating cash flow amounted to SEK 718 M (549), up 31 percent. The cash conversion ratio for the most recent 12-month period amounted to 95 percent (75).
• Items affecting comparability for the quarter totaled SEK -55 M (-49) and pertained to restructuring costs.
• EBITA, including items affecting comparability, amounted to SEK 1,435 M (1,479) for the quarter.
• Earnings per share for continuing operations, excluding items affecting comparability, amounted to SEK 4.23 (3.66), up 16 percent. The improvement is attributable to lower financial costs and the ongoing share repurchase program.
• For the Group as a whole, earnings per share were SEK 4.06 (5.33). The comparable figure in the year-earlier period included a contribution of SEK 1.81 from discontinuing operations.
• Trelleborg Group has decided to establish a new business area, Trelleborg Medical Solutions, in order to increase focus on healthcare & medical.